Related Experiment Video

Updated: Jul 22, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib

Zhimin Zhu1, Qiongni Zhu2

  • 1Department of Pharmaceutics, Shanghai Eighth People's Hospital, Shanghai, China.

Frontiers in Pharmacology
|July 21, 2023
PubMed

Insights

Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) differ in metabolism, transport, and resistance mechanisms. Understanding these differences is key for optimizing cancer treatment effectiveness and safety.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) are vital in treating breast cancer.
  • Understanding drug resistance mechanisms is crucial for global cancer research.
  • Variations among CDK4/6i impact their clinical utility.

Purpose of the Study:

  • To summarize metabolic and transport variations among Abemaciclib, Palbociclib, and Ribociclib.
  • To compare resistance mechanisms of FDA-approved CDK4/6 inhibitors.
  • To discuss how these differences affect anticancer drug efficacy and safety.

Main Methods:

  • Literature search of PubMed, Embase, and Web of Science conducted in March 2023.
  • Review of studies on CDK4/6 inhibitors' metabolism, transport, and resistance.
  • Analysis of preclinical pharmacology, pharmacokinetics, and clinical data.

Main Results:

  • Differences in metabolism and transport exist among CDK4/6i, linked to their chemical structures.
  • Preclinical and clinical data reveal variations in pharmacology, pharmacokinetics, safety, and efficacy.
  • Factors like genetic mutations and drug tolerance influence resistance, but specific differences among the three drugs are largely unknown.

Conclusions:

  • Despite shared function, Abemaciclib, Palbociclib, and Ribociclib exhibit distinct properties.
  • Further research is needed to elucidate the specific resistance mechanisms for each CDK4/6 inhibitor.
  • Understanding these differences is essential for advancing personalized cancer therapy.
Keywords:
AbemaciclibCDK4/6 inhibitorsPalbociclibRibociclibdrug resistancemetabolizer transporttargeted therapy

More Related Videos

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

46.4K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
470
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
593
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
86
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.9K
Drug Absorption Mechanism: Passive Membrane Transport01:23

Drug Absorption Mechanism: Passive Membrane Transport

Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...
4.1K